Application of spin label electron paramagnetic resonance in the diagnosis and prognosis of cancer and sepsis

Clinical Chemistry and Laboratory Medicine

Volumn 46, Issue 9, 2008, Pages 1203-1210

  Gurachevsky, Andrey ^a   Kazmierczak, Steven C ^b   Jörres, Achim ^c   Muravsky, Vladimir ^a  

^a MedInnovation GmbH   (Germany)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Albumin; Cancer; Diagnostic medicine; Electron paramagnetic resonance spectroscopy; Sepsis

Indexed keywords

ALBUMIN;

ATHEROSCLEROSIS; CANCER DIAGNOSIS; DIABETES MELLITUS; ELECTRON SPIN RESONANCE; HUMAN; INFORMATION PROCESSING; NEOPLASM; PRIORITY JOURNAL; PROGNOSIS; QUALITY CONTROL; REVIEW; SEPSIS; SPIN LABELING; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ALBUMINS; ELECTRON SPIN RESONANCE SPECTROSCOPY; HUMANS; NEOPLASMS; PROGNOSIS; SEPSIS; SPIN LABELS;

EID: 51849130372     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2008.260     Document Type: Review

References (38)

1. Etzioni R, Urban S, Ramsey M, McIntosh S, Schwartz B, Reid J, et al. The case for early detection. Nat Rev Cancer 2003;3:243-52.
2. Villanueva DR, Shaffer J, Philip CA, Chaparro H, Erdjument-Bromage AB, Olshen M, et al. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest 2006;116:271-84.
3. Dennis MS, Zhang M, Meng YG, Kadkhodayan D, Kirchofer D, Combs D, et al. Albumin binding as a general strategy for improving pharmacokinetics of proteins. J Biol Chem 2002;277:35035-43.
4. Lowenthal MS, Mehta AI, Frogale K, Bandle RW, Araujo RP, Hood BL, et al. Analysis of albumin-associated peptides and proteins from ovarian cancer patients. Clin Chem 2005;51:1933-45.
5. Oettl K, Stauber RE. Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties. Br J Pharmacol 2007;151:580-90.
6. Bar-Or D, Winkler JV, Vanbenthuysen K, Harris L, Lau E, Hetzel FW. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I. Am Heart J 2001;141:985-91.
7. Apple FS, Wu AH, Mair J, Ravkilde J, Panteghini M, Tate J, et al. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem 2005;51:810-24.
8. Mehta AI, Ross S, Lowenthal MS, Fusaro V, Fishman DA, Petricoin EF III, et al. Biomarker amplification by serum carrier protein binding. Dis Markers 2003;19:1-10.
9. Gurachevsky A, Shimanovitch E, Gurachevskaya T, Muravsky V. Intra-albumin migration of bound fatty acid probed by spin label ESR. Biochem Biophys Res Commun 2007;360:852-6.
10. Kazmierczak SC, Gurachevsky A, Matthes G, Muravsky V. Electron spin resonance spectroscopy of serum albumin: a novel new test for cancer diagnosis and monitoring. Clin Chem 2006;52:2129-34.
11. Livshits VA, Marsh D. Fatty acid binding sites of serum albumin probed by non-linear spin-label EPR. Biochim Biophys Acta 2000;1466:350-60.
12. Hubbell WL, Cafiso DS, Altenbach C. Identifying conformational changes with site-directed spin labeling. Nat Struct Biol 2000;7:735-9
13. Curry S, Mandelkow H, Brick P, Franks N. Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat Struct Biol 1998;5:827-35.
14. Peters T. All about albumin: biochemistry, genetics, and medical applications. San Diego, CA: Academic Press, 1996.
15. Levitt MH. Spin dynamics: basics of nuclear magnetic resonance. Chichester: John Wiley & Sons, 2001.
16. Perkins RC Jr, Abumrad N, Balasubramanian K, Dalton LR, Beth AH, Park JH, et al. Equilibrium binding of albumin in human blood plasma. Eur J Biochem 1990;189:343-9.
17. Berliner LJ. Spin labeling: theory and applications. New York: Academic Press, 1976.
18. Strancar J. EPRSIM-C: a spectral analysis package. http://www.ijs.si/ijs/ dept/epr/EPRSIMC_overview.htm. Accessed March 12, 2008.
19. Stoll S, Schweiger A. EasySpin, a comprehensive software package for spectral simulation and analysis in EPR. J Magn Reson 2006;178:42-55.
20. Matthes G, Seibt G, Muravsky V, Hersmann G, Dornheim G. Albumin transport analysis of different collected and processed plasma products by electron spin resonance spectroscopy. Transfus Apher Sci 2002;27:129-35.
21. Muravskaya EV, Lapko AG, Muravskii VA. Modification of transport function of plasma albumin during atherosclerosis and diabetes mellitus. Bull Exp Biol Med 2003;135:433-5.
22. Gurachevsky A, Muravsky V, Matthes G. Changes in serum albumin measured by electron spin resonance: in vitro diagnostic EPR test. Proc Int Soc Magn Reson Med 2007;15:1323.
23. Muravsky V, Gurachevsky A, Matthes G. Disease specific albumin patterns defined by electron spin resonance. Tumor Biol 2007;28(Suppl 1):19.
24. Gurachevsky A, Muravskaya E, Gurachevskaya T, Smirnova L, Muravsky V. Cancer-associated alteration in fatty acid binding to albumin studied by spin-label electron spin resonance. Cancer Invest 2007;25:378-83.
25. Swartz HM, Khan N, Buckey J, Comi R, Gould L, Grinberg O, et al. Clinical applications of EPR: overview and perspectives. NMR Biomed 2004;17:335-51.
26. Khan N, Williams BB, Hou H, Li H, Swartz HM. Repetitive tissue pO2 measurements by electron paramagnetic resonance oximetry: current status and future potential for experimental and clinical studies. Antioxid Redox Signal 2007;9:1169-82.
27. Swartz HM, Iwasaki A, Walczak T, Demidenko E, Salikhov I, Khan N, et al. In vivo EPR dosimetry to quantify exposures to clinically significant doses of ionising radiation. Radiat Prot Dosimetry 2006;120:163-70.
28. Swartz HM, Halpern H. EPR studies of living animals and related model systems (in vivo EPR). In: Berliner LJ, editor. Spin labeling. The next millennium. New York: Plenum Press, 1998:367-404.
29. Javrid E, Mashevsky A, Muravsky V, Prokchorova V, Korotkevich E, Milutin A. A comparative study of conformation properties of human serum albumin in lung cancer by spin probe technique. Ann Oncol 1994;5(Suppl 8):9.
30. Mashevsky A, Muravsky V, Prokchorova V, Milutin A. Comparative investigation of long chain fatty acid binding sites of normal serum albumin with the one from lung cancer patients carried out by the spin probe method. In: Grizunov J, Dobretsov E, editors. Blood serum albumin in clinical medicine. Moscow: IRUS, 1994.
31. Glowacki R, Jakubowski H. Cross-talk between Cys34 and lysine residues in human serum albumin revealed by N-homocysteinylation. J Biol Chem 2004;279:10864-71.
32. Mashevsky A, Muravsky V, Milutin A, Javrid E, Korotkevich E, Prokchorova V, et al. Dynamics of ESR spectra of the spin labeled blood serum under neoplastic process. Ukr Radiol Zh 1994;4:268-70.
33. Mashevsky A. Diagnosis of the main types of malignant tumors by biochemical and biophysical blood parameters. Doctoral thesis. Research Institute for Oncology and Medical Radiology, Minsk, Belarus, 1994.
34. Bourdon E, Loreau N, Blache D. Glucose and free radicals impair the antioxidant properties of serum albumin. FASEB J 1999;13:233-44.
35. Jakubowski H. The molecular basis of homocysteine thiolactone-mediated vascular disease. Clin Chem Lab Med 2007;45:1704-16.
36. Jakubowski H. Homocysteine is a protein amino acid in humans. Implications for homocysteine-linked disease. J Biol Chem 2002;277:30425-8.
37. Perna AF, Satta E, Acanfora F, Lombardi C, Ingrosso D, De Santo NG. Increased plasma protein homocysteinylation in hemodialysis patients. Kidney Int 2006;69:869-76.
38. Klammt S, Mitzner S, Stange J, Brinkmann B, Drewelow B, Emmrich J, et al. Albumin-binding function is reduced in patients with decompensated cirrhosis and correlates inversely with severity of liver disease assessed by model for end-stage liver disease. Eur J Gastroenterol Hepatol 2007;19:257-63.